Nyxoah SA (NYXH): Price and Financial Metrics Recent IPO


Nyxoah SA (NYXH): $29.13

-0.27 (-0.92%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NYXH Stock Price Chart Interactive Chart >

Price chart for NYXH

NYXH Price/Volume Stats

Current price $29.13 52-week high $37.00
Prev. close $29.40 52-week low $23.15
Day low $29.10 Volume 1,300
Day high $30.31 Avg. volume 22,024
50-day MA $31.87 Dividend yield N/A
200-day MA $0.00 Market Cap 726.59M

Nyxoah SA (NYXH) Company Bio


Nyxoah S.A., a health-technology company, focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. It offers Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treast moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is based in Mont-Saint-Guibert, Belgium.


NYXH Latest News Stream


Event/Time News Detail
Loading, please wait...

NYXH Latest Social Stream


Loading social stream, please wait...

View Full NYXH Social Stream

Latest NYXH News From Around the Web

Below are the latest news stories about Nyxoah SA that investors may wish to consider to help them evaluate NYXH as an investment opportunity.

Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse

INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse Mont-Saint-Guibert (Belgium), September 14, 2021, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that

Yahoo | September 14, 2021

Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference

Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference Mont-Saint-Guibert (Belgium), September 13, 2021, 10:30 pm CET / 4:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, will participate at the Cantor 2021 Global Healthcare Conf

Yahoo | September 13, 2021

Information on the total number of voting rights and shares

REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), September 12, 2021, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of 1,400,000 new warrants on September 8, 2021 and the issue of 82,500 new shares on September 10, 2021 pursuant to the exercise of subscription

Yahoo | September 12, 2021

Nyxoah Announces Participation in the Baird 2021 Global Healthcare Conference

PRESS RELEASE Nyxoah Announces Participation in the Baird 2021 Global Healthcare Conference Mont-Saint-Guibert, Belgium – September 2, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, and Fabian Suarez, Chief Financial Officer, will particip

Yahoo | September 2, 2021

Publication relating to transparency notifications

PRESS RELEASE REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), September 1, 2021, 10.30pm CET / 4.30pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received two transparency notifications as detailed below. Robelga SRL / Robert Taub On August 27, 2021, Nyxoah received a transparency notification from Robelga SRL following the

Yahoo | September 1, 2021

Read More 'NYXH' Stories Here

NYXH Price Returns

1-mo -11.73%
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7824 seconds.